Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC
Aim: Intravesical Bacillus Calmette–Guérin (BCG) is the standard therapy for non-muscle invasive bladder cancer (NMIBC); however, many patients experience recurrence or progression. We examined how urinary immune signals and the urinary microbiome change across BCG and are related to outcomes. Metho...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Open Exploration Publishing Inc.
2026-04-01
|
| Seri Bilgileri: | Exploration of Targeted Anti-tumor Therapy |
| Konular: | |
| Online Erişim: | https://www.explorationpub.com/uploads/Article/A1002365/1002365.pdf |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|